CDK2 and colorectal carcinoma: However, the four CDKs did not show a significant influence on the survival rate of patients (Supplementary Figure 1), which means that although CDK1, CDK2, CDK4, and CDK6 could possibly determine the phenotypes of CRC, the CDKs could not increase the mortality rate of CRC patients.